Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates

分组1 - Sol-Gel Technologies Ltd. reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of a loss of $0.20 per share, and showing improvement from a loss of $0.22 per share a year ago, resulting in an earnings surprise of 135% [1] - The company generated revenues of $5.43 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 414.98%, compared to revenues of $0.59 million in the same quarter last year [2] - Sol-Gel Technologies has outperformed consensus EPS estimates two times over the last four quarters, indicating a positive trend in revenue performance [2] 分组2 - The stock has underperformed the market, losing about 62% since the beginning of the year, while the S&P 500 has gained 16.2% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.21 on revenues of $0.74 million, and for the current fiscal year, it is -$0.83 on revenues of $3.35 million [7] - The Medical - Generic Drugs industry, to which Sol-Gel Technologies belongs, is currently ranked in the top 17% of over 250 Zacks industries, suggesting a favorable industry outlook [8]